SwePub
Sök i LIBRIS databas

  Extended search

L773:1755 5914
 

Search: L773:1755 5914 > (2011) > Effect on Mode of D...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Krum, Henry (author)

Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial

  • Article/chapterEnglish2011

Publisher, publication year, extent ...

  • 2011-02-24
  • Wiley,2011

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:ca2e4382-ea6e-4491-a41b-a9734ff76a34
  • https://lup.lub.lu.se/record/1869953URI
  • https://doi.org/10.1111/j.1755-5922.2010.00185.xDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • P>Background: Mode of death in chronic heart failure (CHF) may be of relevance to choice of therapy for this condition. Sudden death is particularly common in patients with early and/or mild/moderate CHF. beta-Blockade may provide better protection against sudden death than ACE inhibition (ACEI) in this setting. Methods: We randomized 1010 patients with mild or moderate, stable CHF and left ventricular ejection fraction < 35%, without ACEI, beta-blocker or angiotensin-receptor-blocker therapy, to either bisoprolol (n = 505) or enalapril (n = 505) for 6 months, followed by their combination for 6-24 months. The two strategies were blindly compared regarding adjudicated mode of death, including sudden death and progressive pump failure death. Results: During the monotherapy phase, 8 of 23 deaths in the bisoprolol-first group were sudden, compared to 16 of 32 in the enalapril-first group: hazard ratio (HR) for sudden death 0.50; 95% confidence interval (CI) 0.21-1.16; P = 0.107. At 1 year, 16 of 42 versus 29 of 60 deaths were sudden: HR 0.54; 95% CI 0.29-1.00; P = 0.049. At study end, 29 of 65 versus 34 of 73 deaths were sudden: HR 0.84; 95% CI 0.51-1.38; P = 0.487. Comparable figures for pump failure death were: monotherapy, 7 of 23 deaths versus 2 of 32: HR 3.43; 95% CI 0.71-16.53; P = 0.124, at 1 year, 13 of 42 versus 5 of 60: HR 2.57; 95% CI 0.92-7.20; P = 0.073, at study end, 17 of 65 versus 7 of 73: HR 2.39; 95% CI 0.99-5.75; P = 0.053. There were no significant between-group differences in any other fatal events. Conclusion: Initiating therapy with bisoprolol compared to enalapril decreased the risk of sudden death during the first year in this mild systolic CHF cohort. This was somewhat offset by an increase in pump failure deaths in the bisoprolol-first cohort.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • van Veldhuisen, Dirk J. (author)
  • Funck-Brentano, Christian (author)
  • Vanoli, Emilio (author)
  • Silke, Bernard (author)
  • Erdmann, Erland (author)
  • Follath, Ferenc (author)
  • Ponikowski, Piotr (author)
  • Goulder, Michael (author)
  • Meyer, Wilfried (author)
  • Lechat, Philippe (author)
  • Willenheimer, RonnieLund University,Lunds universitet,Kardiologiska klinikens forskargrupp,Forskargrupper vid Lunds universitet,Cardiology Research Group,Lund University Research Groups(Swepub:lu)medf-rw0 (author)
  • Kardiologiska klinikens forskargruppForskargrupper vid Lunds universitet (creator_code:org_t)

Related titles

  • In:Cardiovascular Therapeutics: Wiley29:2, s. 89-981755-5914

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view